🔎 Trials Near Me

Home › Epilepsy › Illinois

Pag-aaral pangklinika para sa Epilepsy sa Illinois

8 pag-aaral para sa Epilepsy ang naghahanap ng mga kalahok sa mga site sa Illinois.

Mga Lungsod sa Illinois

Opisyal na teksto ng pag-aaral (English)

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures

  • Re:Cognition Health-Chicago, Chicago
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07594119

A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

  • Northwestern University, Chicago
Nagre-recruitPhase 2/3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT06132893

A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures

  • Southern Illinois University School of Medicine, Springfield
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT05667142

Comparative Effectiveness of Palliative Surgery Versus Additional Anti-Seizure Medications for Lennox-Gastaut Syndrome

  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Nagre-recruitObservasyonal na pag-aaral
Hanggang edad 26 · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT05374824

A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety

  • Praxis Research Site, Chicago
Nagre-recruitPhase 3
1 Day – 18 Years · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT07019922

Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))

  • Rush University Medical Center, Chicago
  • University of Chicago, Chicago
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hun 9, 2026 · NCT05135091

A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)

  • Southern Illinois University School of Medicine, Springfield
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update May 14, 2026 · NCT05716100

Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study

  • Lurie Children's Hospital of Chicago, Chicago
Nagre-recruitPhase 2
1 Day – 6 Months · Lahat ng kasarian · Na-update Ene 22, 2026 · NCT05104983

Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.